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1. Introduction 
We have described anew NADPHdependent 
CoASSG*-reductase from rat liver and yeast [ 1,2] . 
Since this enzyme catalyzes areaction similar to those 
of lipoamide dehydrogenase (EC 1.6.4.3), GSSG*- 
reductase (EC 1.6.4.2) and thioredoxin reductase, 
which are well-known pyridine nucleotide-dependent 
flavoproteins [3-51, we decided to see if the new re 
ductase contains an active site with the particular 
characteristics of this group of enzymes. 
Our studies with arsenite and 5-nitrofuran deri- 
vatives, utilised as inhibitors, indicate that the CoASSG 
reductase contains a disulfide bridge in its active site 
and suggest the presence of FAD as prosthetic group. 
2. Materials and methods 
The preparation and purification of CoASSG, and 
the conditions for the estimation of the enzymic ac- 
tivity have been previously described [ 1,2,6] . 
A commercially purified crystalline suspension of
yeast GSSG-reductase (5mg of protein/ml, 80 units) 
from Boehringer was used as source of yeast CoASSG- 
mreductase (this preparation contains an appreciable acti- 
vity of the new enzyme as contaminant, 2-5 units). 
CoASSG-reductase was also prepared from 100 g 
of rat liver homogenized with 0.1 M sodium phosphate 
buffer (PH 7.4) and centrifuged at 105,OOOg for 30 min. 
* Abbreviations: 
Co-SSGlutathione, CoASSG 
Glutathione-SS-glutathione, GSSG. 
North-Holland PubIishing Company - Amsterdam 
The supernatant was precipitated with ammonium 
sulfate between 40 and 60% saturation, for one hr 
in the cold. After centrifugation at 15,000 g for 15 
min, the precipitate was suspended in 0.1 M phosphate 
buffer @H 7.4) and dialysed. The dialysate was passed 
twice with the same buffer through a Sephadex G-75 
column (5 X 75 cm). The fractions containing both 
reductase activities were precipitated with ammonium 
sulfate at 60% saturation as before. The precipitate was 
dissolved in minimum volume of 0.1 M sodium phos 
phate buffer (pH 7.0) and dialysed overnight. This 
preparation was used for enzyme assay and contained 
22 mg of protein per ml (177 mU of CoASSG-reduc- 
tase). The protein content of the extracts was deter- 
mined by the method of Lowry et al. [7]. 
3. Results 
Since arsenite is known to react with a NADPH- 
dependent reducible SS bridge, forming covalent 
bonds, such as in GSSG-reductase and lipoamide de- 
hydrogenase, with resulting inhibition of enzyme ac- 
tivity [3,4] , the effect of this compound,,was sayed 
on CoASSG-reductase activity from the yeast and rat 
liver. Arsenite was found to inhibit the CoASSG-re- 
ductase activity at 10-l, 10s2 and 10e3 M only when 
it was preincubated with the NADPH-dependent reduced 
enzyme for a minimum period of 3 min. The results 
of incubation for 5 min in the presence of arsenite at 
1O-2 M, with yeast and rat-liver preparations, with or 
without NADPH, appear in figs. 1 and 2. 
It is interesting to note that the CoASSG-reductase 
from rat liver is more sensitive to arsenite than is the 
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Fig. 1. Inhibition of reduced CoASSG-reductase from yeast 
(commercial preparation of yeast GSSG-reductase) by 1O-2 M 
Fig. 2. Inhibition of reduced CoASSG-reductase from rat 
arsenite. The incubation mixtures were prepared as follows: 
liver by 10-2 M arsenite. The incubation mixtures were pre- 
pared as follows: 
(A) 970 ~1 of 0.05 M sodium phosphate buffer (pH 5.5) 
containing 1 mM EDTA, 10 ~1 of NADPH (125 nmoles), 20 
~1 of GSSG-reductase (Boehringer, 5 mg/ml, dil. 1 : 100); 
after 2 min of incubation, 10 ~1 of CoASSG (78 mnoles) were 
added (curve A). 
(A) 950 ~1 of 0.05 M sodium phosphate buffer (pH 5.5) 
containing 1 mM EDTA, 10 l.rl of NADPH (125 nmoles) and 
40 ~1 of partially purified rat-liver extract (22 mg of protein/ 
ml); after 2 min 10 ~1 of CoASSG (78 mnoles) were added 
(curve A). 
(B) This mixture is similar to A, except that 100 ~1 of 
0.1 M arsenite (10 pmoles) were added to the mixture which 
did not contain NADPH; after 5 min of incubation the mix- 
ture was dialysed for 1 h against water and finally equilibrated 
with 0.05 M sodium phosphate buffer (pH 5.5) containing 
1 mM EDTA; then 10 ~1 of NADPH were added (125 nmoles) 
and after 2 min 78 nmoles of CoASSG were mixed (curve B). 
(C) Contained the complete incubation mixture as in A 
plus 100 ~1 of 0.1 M arsenite (10 pmoles). After 5 min of in- 
cubation 78 nmoles of CoASSG were mixed (curve C). The 
same degree of inhibition of this preparation was obtained 
after dialysis. 
(B) This mixture is similar to A, except that 100 pl of 
0.1 M arsenite (10 Mmoles) were added to the mixture which 
did not contain NADPH; after 5 min of incubation the mix- 
ture was dialysed for 1 h against water and finally equili- 
brated with 0.05 M sodium phosphate buffer (pH 5.5) con- 
taining 1 mM EDTA; then 10 ~1 of NADPH were added (125 
nmoles) and after 2 min 78 nmoles of CoASSG were mixed 
(curve B). 
(C) Contained the complete incubation mixture as in A, 
plus 100 ~1 of 0.1 M arsenite (10 @moles); after 5 min of in- 
cubation 10 ~1 of CoASSG (78 nmoles) were mixed (curve C) 
The same degree of inhibition of this preparation was ob 
tamed after dialysis. 
yeast enzyme (see curves C, figs. 1 and 2). If the en- 
zyme from both preparations is not previously reduced 
with NADPH (see curves B, figs. 1 and 2) no inhibiting 
effect was observed. 
The inhibitory effect of arsenite is not reversed by 
dialysis. Longer times of incubation (1 hr) produce 
total inactivation of yeast and rat-liver preparations. 
The 5nitrofuran derivatives [8] utilised in these 
studies as inhibitors of CoASSG-reductase and 
CoASSG 
2 AandB 1 
ARSENITE 
CoASSG 
6 
GSSG-reductase were: furadantin (N&nitro-2-furfu- 
rylidene-1-aminohydantoin), furoxone (N-5-nitro-2- 
furfurylidene-3-amino-2-oxazolidone), micofur (5nitro- 
2-furfuraldehyde oxime), furaspor (5nitrofurfuryl 
methyl ether) and furacin (5-nitro-2-furfuraldehyde 
semicarbazone) at final concentrations of 1 tY4 M in 
the reaction mixtures. During the assay of enzymic ac- 
tivity, blanks of buffer containing an equivalent 
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Table 1 
Inhibition of CoASSG-reductase and GSSG-reductase from yeast and rat-liver by 5-nitrofuran derivatives (104 M). 
Yeast Rat-liver 
CoASSG-reductase GSSG-reductase CoASSG-reductase GSSG-reductase 
A340 nm/min 
Inhibition 
A340 nm/min 
Inhibition 
A340 nm/min 
Inhibition 
A340 mn/min 
Inhibition 
(%) (%) (%) (%) 
Normal activity 0.085 _ 0.130 _ 0.092 _ 0.138 _ 
Furadantin 0.050 41 0.05 1 67 0.061 34 0.042 85 
Furoxone 0.036 58 0.067 48 0.075 19 0.070 75 
Micofur 0.012 86 0.036 72 0.021 77 0.042 85 
Furaspor 0.022 74 0.07 1 45 0.055 40 0.008 97 
Furacin 0.03 1 64 0.045 65 0.041 55 0.025 82 
The GSSG-reductase and CoASSG-reductase activated from yeast (commercial GSSG-reductase from Boehringer) and from parti- 
ally purified rat-liver extracts were measured as follows: for the evaluation of yeast CoASSG-reductase, 20 ~1 of yeast GSSG-re- 
ductase (Boehringer, 5 mg/ml, dil. 1 : loo), 10 ~1 of NADPH (125 nmoles), plus the corresponding substrate (see below) in a final 
volume of 1 ml, made up with 0.05 M sodium phosphate buffer (pH 5.5), containing 1 mM EDTA. For the estimation of yeast 
GSSG-reductase, 5~1 of yeast GSSG-reductase (5 mg/ml, dil. 1 : 500), 10 nl of NADPH, (125 nmoles), plus substrate in a final 
volume of 1 ml, made up with 0.1 M sodium phosphate buffer (pH 7), containing 1 mM EDTA. For the estimation of liver CoASSG 
reductase, 40 ~1 of partially purified rat-liver extract (22 mg of protein/ml), 10 n1 of NADPH (125 nmoles) plus the substrate, in a 
final volume of 1 ml, made up with 0.05 M sodium phosphate buffer (pH 5.5), containing 1 mM EDTA. For liver GSSG-reductase 
5 ~1 of partially purified rat-liver extract (28 mg of protein/ml), 10 ~1 of NADPH (125 nmoles), plus substrate in a final volume of 
1 ml, made up with 0.1 M sodium phosphate buffer (pH 7), containing 1 mM EDTA. The 5-nitrofuran derivatives and NADPH 
were added to the enzyme preparations 20 min before the beginning of each experiment; after this period of time, the correspond- 
ing substrate was added (750 nmoles of GSSG or 78 mnoles of CoASSG) and the NADPH consumption recorded in an automatic 
Beckman DK-2 spectrophotometer at 340 run. The initial velocities of the reactions were measured and appear in the table ex- 
pressed as change in 34b nm/min. 
amount of the respective nitrofuran derivatives were 
used. 
In order to evaluate the reversibility of inhibition, 
in some experiments the incubation mixtures which 
contained the enzyme, NADPH and 5-nitrofuran deri- 
vatives, were dialysed overnight against cold water, fol- 
lowed by a two-hour dialysis against phosphate buffer. 
The inhibition was reversed by dialysis and was inde- 
pendent of the presence of NADPH, whether added 
before or after the incubation of the enzyme with 
nitrofuran derivatives. The inhibiting effects on both 
enzymes are shown in table 1. 
It may be noted, apart from the main purpose of 
this work, that the yeast CoASSG-reductase is more 
sensitive to inhibition by 5nitrofuran derivatives, than 
is the rat-liver enzyme, especially with furoxone and 
furaspor. On the other hand, the GSSG-reductase from 
yeast is less affected by these inhibitors than the res- 
pective enzyme from rat-liver. 
4. Conclusions 
On the basis of the results of inhibition of CoASSG- 
reductase obtained under the conditions here estab- 
lished, we conclude that: 
(a) There is present a disulfide bridge, as evidenced 
by the fact that the enzyme is inhibited by arsenite, 
provided that it has been previously reduced with 
NADPH. The inhibition by arsenite is not removed 
after dialysis. 
(b) The CoASSG-reductase from rat liver and yeast 
must be a flavoprotein. This proposition can be made 
because S-nitrofuran derivatives are known to compete 
with flavoproteins, as shown by Buzard and Kopko 
[8] for the GSSG-reductase from rat-liver. In our 
studies this effect is also independent of the addition 
of NADPH and can be reversed by dialysis. 
The above findings indicate the existence in CoASSG- 
reductase of an active site probably similar in its basic 
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catalytic mechanism to lipoamide dehydrogenase and 
GSSG-reductase [3,4]. Direct studies in support of 
this conclusion can be performed only when highly 
purified preparations are available. 
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